News

4 UCSF Faculty Elected to American Academy of Arts and Sciences' 2015 Class

4 UCSF Faculty Elected to American Academy of Arts and Sciences' 2015 Class

April 22, 2015

Renowned UC San Francisco pioneers in cancer, biochemistry, medical genetics and pharmaceutical sciences have been elected as members of the American Academy of Arts and Sciences, which recognizes the world’s most accomplished leaders in science, humanities, arts, business and public affairs.

 
UCSF joins lung cancer dream team

UCSF joins lung cancer dream team

April 20, 2015

Previous HDFCCC director and long-time RAS researcher Frank McCormick will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C)-American Cancer Society $20 million Dream Team to combat lung cancer.

Angiogenesis Inhibitors Undermined by Immune Cells, Says Study

Angiogenesis Inhibitors Undermined by Immune Cells, Says Study

April 16, 2015

Angiogenesis inhibitors—a widely used class of cancer drugs designed to shrink tumors by preventing them from forming new blood vessels—often work in the short term, but usually become ineffective within months.

California Launches Initiative to Advance Precision Medicine

California Launches Initiative to Advance Precision Medicine

April 14, 2015

Gov. Jerry Brown is launching a statewide initiative with the University of California, to advance the field of precision medicine. The effort will involve collaborating with other academic and industry partners and starting to build the infrastructure and assemble the resources necessary to further develop the field.
Dual Therapy’s One-Two Punch Knocks Out Drug-Resistant Lung Cancer

Dual Therapy’s One-Two Punch Knocks Out Drug-Resistant Lung Cancer

April 2, 2015

Capitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had developed resistance to targeted drug treatment, UC San Francisco scientists identified a biological escape hatch that explains the resistance, and developed a strategy in mice for shutting it down.
 
Immunotherapy: A Field Whose Day Has Come

Immunotherapy: A Field Whose Day Has Come

April 1, 2015

In closing the 2015 UCSF Helen Diller Family Comprehensive Cancer Center Symposium, President Alan Ashworth, PhD, FRS, counted himself among those who might once have underappreciated the full potential of cancer immunotherapy. “But,” he declared, “it is clearly a field whose day has come.” He ...